Showing results (271-280 of 878) with videos related to

Sort By:
Pageof 88
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1992
Efficacy of single-dose azithromycin versus doxycycline in the treatment of cervical infections caused by Chlamydia trachomatisJ M Ossewaarde, F H Plantema, M Rieffe, et al.
The Netherlands Journal of Medicine|August 1, 1992
Ursodeoxycholic acid treatment in primary biliary cirrhosis with the emphasis on late stage diseaseJ C Kneppelhout, C J Mulder, G P van Berge Henegouwen, et al.
Journal of Virological Methods|June 26, 2007
A rapid and sensitive assay for detection of replication-competent adenoviruses by a combination of microcarrier cell culture and quantitative PCRJohanna A C Schalk, Claudette G J C A de Vries, Tom J H Orzechowski, et al.
Cancer Chemotherapy and Pharmacology|December 20, 2005
Multidrug resistance proteins and folate supplementation: therapeutic implications for antifolates and other classes of drugs in cancer treatmentJ H Hooijberg, N A de Vries, G J L Kaspers, et al.
BMJ Public Health|October 2, 2025
Trends in myopia prevalence and projected visual impairment in Western Europe: a pooled analysis of Dutch population-based cohorts (1900-2000)Sander Kneepkens, Clair A Enthoven, Jan Roelof Polling, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 1, 2013
Oxidative DNA damage in humans: comparison between high and low habitual fruit and vegetable consumptionM G Hertog, A de Vries, M C Ocké, et al.
Journal of Clinical Microbiology|June 2, 2000
Monoclonal antibodies directed against conserved epitopes on the nucleocapsid protein and the major envelope glycoprotein of equine arteritis virusE Weiland, S Bolz, F Weiland, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositisG M Sprinzl, O Galvan, A de Vries, et al.
Investigational New Drugs|October 22, 2010
Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRPNienke A de Vries, Tessa Buckle, Jin Zhao, et al.
Transplant Immunology|December 16, 1998
An alternative conditioning regimen for induction of specific skin graft tolerance across full major histocompatibility complex barriersA de Vries-van der Zwan, M A van der Pol, L P de Waal, et al.
Pageof 88